Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,024.09 20.57 (1.97%) as of 4:30 Wed 7/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 107.21(B)
Last Volume: 378,341 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 191,758 236,826 311,409 468,643
Total Sell Value $188,359,854 $231,314,072 $294,701,490 $404,818,815
Total People Sold 7 13 16 18
Total Sell Transactions 16 39 65 127
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 2433
  Page 62 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Van Plew Daniel P SVP & Gen Mgr IOPS   •       –      –    2013-09-18 4 AS $298.28 $7,269,042 D/D (23,977) 10,736     -
   Van Plew Daniel P SVP & Gen Mgr IOPS   •       –      –    2013-09-17 4 D $294.75 $8,407,154 D/D (28,523) 34,713     -
   Van Plew Daniel P SVP & Gen Mgr IOPS   •       –      –    2013-09-17 4 OE $16.80 $882,000 D/D 52,500 63,236     -
   Schleifer Leonard S CEO & President   •       •      –    2013-09-09 4 AS $275.04 $1,377,332 I/I (5,000) 0     -
   Schleifer Leonard S CEO & President   •       •      –    2013-09-09 4 A $0.00 $0 I/I 5,000 5,000     -
   Landry Robert E SVP Fin, Dep CFO   •       –      –    2013-09-09 4 A $0.00 $0 D/D 5,000 5,000     -
   Ryan Arthur F Director   –       •      –    2013-08-23 4 S $238.47 $2,613,154 D/D (10,958) 49,855     -
   Goldstein Joseph L Director   –       •      –    2013-08-23 4 S $238.29 $238,290 D/D (1,000) 4,000     -
   Ryan Arthur F Director   –       •      –    2013-08-22 4 D $236.64 $956,499 D/D (4,042) 60,813     -
   Ryan Arthur F Director   –       •      –    2013-08-22 4 OE $18.61 $956,900 D/D 30,000 62,019     -
   Goldstein Joseph L Director   –       •      –    2013-08-14 4 A $0.00 $0 D/D 5,000 5,000     -
   Goldberg Murray A SVP Finance and Admin CFO and   •       –      –    2013-08-01 4 OE $16.80 $84,000 D/D 5,000 63,554     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-07-05 4 GD $0.00 $0 I/I 921 159,267     -
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2013-06-17 4 OE $24.00 $93,600 D/D 3,900 15,600     -
   Roberts William VP Reg Dev & Med Safety   •       –      –    2013-06-13 4 GD $0.00 $0 I/I 4,000 13,447     -
   Roberts William VP Reg Dev & Med Safety   •       –      –    2013-06-13 4 GA $0.00 $0 D/D 4,000 20,644     -
   Baker Charles A Director   –       •      –    2013-06-10 4 AS $250.06 $3,777,547 D/D (15,000) 9,000     -
   Baker Charles A Director   –       •      –    2013-06-10 4 OE $15.80 $237,000 D/D 15,000 24,000     -
   Ryan Arthur F Director   –       •      –    2013-05-31 4 S $249.45 $623,885 D/D (2,500) 34,855     -
   Goldstein Joseph L Director   –       •      –    2013-05-28 4 S $252.20 $1,008,800 D/D (4,000) 0     -
   Ryan Arthur F Director   –       •      –    2013-05-23 4 GD $0.00 $0 D/D 3,000 37,355     -
   Goldberg Murray A SVP Finance and Admin CFO and   •       –      –    2013-05-21 4 AS $255.52 $17,359,652 D/D (66,835) 58,554     -
   Goldberg Murray A SVP Finance and Admin CFO and   •       –      –    2013-05-21 4 OE $16.80 $78,396 D/D 4,023 125,389     -
   Goldberg Murray A SVP Finance and Admin CFO and   •       –      –    2013-05-21 4 GD $0.00 $0 D/D 4,061 121,366     -
   Goldstein Joseph L Director   –       •      –    2013-05-20 4 A $0.00 $0 D/D 4,000 4,000     -
  2433 Records found
  Previous  60  61  62  63  64  65  66  67  68  69  Next   
  Page 62 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us